Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes

被引：0
|
作者：
Patricia K Coyle
Bruce A Cohen
Thomas Leist
Clyde Markowitz
MerriKay Oleen-Burkey
Marc Schwartz
Mark J Tullman
Howard Zwibel
机构：
[1] Stony Brook University,Department of Neurology
[2] Health Sciences Center T12-020,Department of Neurology
[3] Northwestern University,Multiple Sclerosis Center at Penn
[4] Comprehensive MS Center,undefined
[5] Thomas Jefferson University,undefined
[6] University of Pennsylvania,undefined
[7] Health Outcomes Research Consulting and Writing,undefined
[8] Outcomes Scribe,undefined
[9] LLC,undefined
[10] Biostatistics,undefined
[11] MedNet Solutions,undefined
[12] Inc,undefined
[13] The MS Center for Innovations in Care,undefined
[14] Missouri Baptist Medical Center,undefined
[15] Neuroscience Consultants,undefined
[16] Comprehensive Multiple Sclerosis Center,undefined
来源：
BMC Neurology | / 14卷
关键词：
Multiple sclerosis; Disease-modifying therapy; Compliance; Relapses; Disability; Quality of life; Work productivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Concomitant therapy for multiple sclerosis
    Stuart, WH
    Vermersch, P
    NEUROLOGY, 2004, 63 (11) : S28 - S34
  • [42] Interferon β therapy for multiple sclerosis
    Goodkin, DE
    LANCET, 1998, 352 (9139): : 1486 - 1487
  • [43] Interferon therapy of multiple sclerosis
    Hohlfeld, R
    ADVANCES AND CONTINUING EDUCATION IN MEDICINE, VOL 20, (1996/97), 1996, 20 : 211 - 213
  • [44] Natalizumab Therapy of Multiple Sclerosis
    Hutchinson, Michael
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2010, 30 (10): : 787 - 789
  • [45] Natalizumab Therapy for Multiple Sclerosis
    Chataway, Jeremy
    Miller, David H.
    NEUROTHERAPEUTICS, 2013, 10 (01) : 19 - 28
  • [46] Daclizumab Therapy for Multiple Sclerosis
    Bibiana Bielekova
    Neurotherapeutics, 2013, 10 : 55 - 67
  • [47] The future of multiple sclerosis therapy
    Kieseier, Bernd C.
    Wiendl, Heinz
    Hartung, Hans-Peter
    Stueve, Olaf
    PHARMACOLOGICAL RESEARCH, 2009, 60 (04) : 207 - 211
  • [48] THERAPY OF MULTIPLE-SCLEROSIS
    JERUSALEM, F
    WUTHRICH, R
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1980, 69 (11): : 349 - 354
  • [49] Antiglutamatergic therapy for multiple sclerosis?
    Hohlfeld, Reinhard
    Kerschensteiner, Martin
    LANCET NEUROLOGY, 2016, 15 (10): : 1003 - +
  • [50] Immunosuppressive therapy for multiple sclerosis
    Gauthier, SA
    Buckle, GJ
    Weiner, HL
    NEUROLOGIC CLINICS, 2005, 23 (01) : 247 - +
12345